The DEA has forwarded a petition to reschedule psilocybin from Schedule I to Schedule II, prompting HHS review. Here’s what this means for businesses, IRS 280E, and the future of the psychedelics industry.
Calyx CPA
Cannabis & Psychedelic Services Accounting Specialists